Vanity Capital Inc.
Vanity Capital Inc. Enters Into Letter of Intent With XynaRx Pharmaceuticals Corp.
Vancouver, British Columbia--(Newsfile Corp. - March 14, 2019) - Vanity Capital Inc. (TSXV: VYC) (the "Company") and XynaRx Pharmaceuticals Corp. ("XynaRx") are pleased to announce the entering into of an arm's length binding letter of intent (the "LOI") accepted effective March 11, 2019, pursuant to which the Company will acquire ...2019-03-14 9:00 AM ET
Vanity Capital Inc. and Akseera Pharma Corp. Announces Reverse Takeover Transaction and Concurrent Financing
Vancouver, British Columbia--(Newsfile Corp. - November 28, 2018) - Vanity Capital Inc. (TSXV: VYC) (the "Company") is pleased to announce that it has entered into a binding letter of intent dated Nov. 27, 2018, (the "Letter of Intent") with Akseera Pharma Corp., a private Canadian corporation ("Akseera"), in connection with ...2018-11-28 2:06 PM ET